SNW:ETR
Sanofi SA
€84,86
arrow_upward
+1,30%(+1,09) 1D
20 Nov., 17:35:55 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNW...
Open
€84,20
High
€85,50
Low
€84,20
Mkt. cap
102,57Â mjd.
Avg. vol.
15,14Â k
Volume
10,50Â k
P/E ratio
24,40
52-wk high
€88,99
52-wk low
€69,77
EPS
€3,48
Shares outstanding
1,25Â mjd.
No. of employees
75Â k
Open
€84,20
High
€85,50
Low
€84,20
Mkt. cap
102,57Â mjd.
Avg. vol.
15,14Â k
Volume
10,50Â k
P/E ratio
24,40
52-wk high
€88,99
52-wk low
€69,77
EPS
€3,48
Shares outstanding
1,25Â mjd.
No. of employees
75Â k
News stories
From web sources and news partners
Genetic Engineering and Biotechnology News
·
3 uur gelede
StockWatch: Insmed Jumps on Report of Takeover Interest by Sanofi, as Analysts Conclude a Deal Would Make Sense
ad-hoc-news.de
·
4 uur gelede
Sanofi stock: Nov. 24 investor event follows two drug approvals
Investor's Business Daily
·
3 dae gelede
Sanofi Reportedly Mulls The Biggest Biotech Deal In Years
Barron's
·
3 dae gelede
Insmed Stock Jumps as Sanofi Eyes Takeover, Report Says
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOBelén Garijo | Paul Hudson
Employees74,8Â k
Founded1973
HeadquartersParys, ÃŽle-de-France, Frankryk
SectorHealth Care
IndustryPharmaceutical industry
Websitesanofi.com